Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity

by on 23 de gener de 2023 with No hi ha comentaris
  • Rosás-Umbert, M., Gunst, J. D., Pahus, M. H., Olesen, R., Schleimann, M., Denton, P. W., Mothe, B., Brander, C., . . . Søgaard, O. S. (2022). Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity. Nature Communications, 13(1), 6473. https://doi.org/10.1038/s41467-022-34171-2

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *